Home › Companies › TEVA PHARMACEUTICAL INDUSTRIES LTD. › 2023-2024

TEVA PHARMACEUTICAL INDUSTRIES LTD. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and TEVA PHARMACEUTICAL INDUSTRIES LTD.’s Form 8-K, filed 2024-06-06 (Item 5.07 on EDGAR). Page generated 04 October 2026.

20Reported items
490Asset managers
3,105Fund votes
2024-06-06Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TEVA PHARMACEUTICAL INDUSTRIES LTD. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by TEVA PHARMACEUTICAL INDUSTRIES LTD.

These tallies are TEVA PHARMACEUTICAL INDUSTRIES LTD.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TEVA PHARMACEUTICAL INDUSTRIES LTD. — official shareholder meeting results, meeting held 2024-06-06
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Prof. Varda Shalev	602,030,429	91,772,897	2,121,621	--	77,433,361	Majority: yes
Elect Director: Rosemary A. Crane	511,812,296	181,995,022	2,117,693	--	77,433,361	Majority: yes
Elect Director: Gerald M. Lieberman	560,335,672	133,450,043	2,139,232	--	77,433,361	Majority: yes
Elect Director: Prof. Ronit Satchi-Fainaro	517,677,574	176,129,338	2,118,035	--	77,433,361	Majority: yes
(2) The shareholders approved, on a non-binding advisory basis, the compensation for Teva's named executive officers listed in the proxy statement for the Annual Meeting, as follows:	571,822,049	120,609,632	3,493,266	--	77,433,361	Majority: yes
(3) The shareholders recommended, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation for Teva's named executive officers every one year, as follows:	731,150,255	30,335,560	5,096,971	--	0	Majority: yes

Source: TEVA PHARMACEUTICAL INDUSTRIES LTD., Form 8-K, filed with the SEC on 2024-06-06 — read the filing on EDGAR.

How asset managers voted at the TEVA PHARMACEUTICAL INDUSTRIES LTD. 2023-2024 meeting

Each item below shows how the 490 asset managers that disclosed a TEVA PHARMACEUTICAL INDUSTRIES LTD. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of TEVA PHARMACEUTICAL INDUSTRIES LTD.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Combines 20 wordings of this item as funds reported it.

91% fund support · no official result

FOR 90%9%

The 458 asset managers below cast 91% of the shares they voted on this item FOR (461,859,608 for, 48,322,391 against).

FOR: 461,859,608 (90.2%)AGAINST: 48,322,391 (9.4%)ABSTAIN: 1,876,269 (0.4%)NOT VOTED: 20,699 (0.0%)

Largest asset managers voting on “To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers.” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Against	Vote
Fidelity	65,699,009	0	For
BlackRock	48,709,030	0	For
Vanguard	38,240,313	0	For
Harel Insurance Investments & Financial Services Ltd.	33,092,396	0	For
MENORA MIVTACHIM HOLDINGS LTD.	28,838,038	0	For
Clal Insurance Enterprises Holdings Ltd	27,896,249	0	For
Slate Path Capital LP	26,896,184	0	For
Lingotto Investment Management LLP	18,075,213	0	For
State Street	306,528	16,051,579	Against
Rubric Capital Management LP	15,202,683	0	For
AustralianSuper Pty Ltd	0	10,040,239	Against
PointState Capital LP	8,787,795	0	For
GEODE CAPITAL MANAGEMENT, LLC	8,165,783	0	For
Neuberger Berman	7,062,568	0	For
Y.D. More Investments Ltd	0	6,580,083	Against
Capital Group	6,345,669	40	For
Charles Schwab	6,324,448	0	For
Holocene Advisors, LP	5,672,613	0	For
Alyeska Investment Group, L.P.	5,671,232	0	For
Renaissance	5,303,159	0	For
Northern Trust	4,808,025	19,267	For
Legal & General Investment Management Ltd	0	4,703,885	Against
Maple Rock Capital Partners Inc.	4,363,400	0	For
Parsifal Capital Management, LP	4,306,975	0	For
MARSHALL WACE, LLP	3,824,293	0	For

Showing the 25 largest of 458 asset managers. See all 458 in the interactive database.

2. To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensation for Teva's named executive officers every one, two or three years.

SECTION 14A SAY-ON-PAY VOTES

Combines 13 wordings of this item as funds reported it.

99.9% fund support · no official result

ONE YEAR 66%1 YEAR 32%

The 434 asset managers below cast 99.9% of the shares they voted on this item FOR (2,684,392 for, 20 against).

FOR: 2,684,392 (0.6%)AGAINST: 20 (0.0%)ABSTAIN: 1,617,189 (0.4%)ONE YEAR: 287,185,692 (65.8%)1 YEAR: 138,487,010 (31.8%)3 YEARS: 4,381,042 (1.0%)THREE YEARS: 1,292,567 (0.3%)1-YEAR: 459,714 (0.1%)NOT VOTED: 20,699 (0.0%)2 YEARS: 2,028 (0.0%)1: 220 (0.0%)FOR 1 YEAR: 33 (0.0%)

Largest asset managers voting on “To recommend, on a non-binding advisory basis, to hold a non- binding advisory vote to approve the compensatio” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Fidelity	0	0	0	0	One Year
BlackRock	0	0	0	0	One Year
Vanguard	0	0	0	0	One Year
Harel Insurance Investments & Financial Services Ltd.	0	0	0	0	One Year
Slate Path Capital LP	0	0	0	0	1 Year
Lingotto Investment Management LLP	0	0	0	0	1 Year
State Street	0	0	0	0	One Year
Rubric Capital Management LP	0	0	0	0	1 Year
AustralianSuper Pty Ltd	0	0	0	0	1 Year
PointState Capital LP	0	0	0	0	1 Year
GEODE CAPITAL MANAGEMENT, LLC	0	0	0	0	One Year
Neuberger Berman	0	0	0	0	1 Year
Capital Group	0	0	0	0	One Year
Holocene Advisors, LP	0	0	0	0	1 Year
Alyeska Investment Group, L.P.	0	0	0	0	One Year
Renaissance	0	0	0	0	One Year
Northern Trust	0	0	0	0	1 Year
Legal & General Investment Management Ltd	0	0	0	0	One Year
Maple Rock Capital Partners Inc.	0	0	0	0	3 Years
Parsifal Capital Management, LP	0	0	0	0	1 Year
MARSHALL WACE, LLP	0	0	0	0	1 Year
Victory Capital	0	0	0	0	One Year
Nuveen	0	0	0	0	One Year
TIAA	0	0	0	0	One Year
MELLON INVESTMENTS Corp	0	0	0	0	One Year

Showing the 25 largest of 434 asset managers. See all 434 in the interactive database.

3. Election of Directors: Gerald M. Lieberman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%AGAINST 19%

FOR: 560,335,672AGAINST: 133,450,043

TEVA PHARMACEUTICAL INDUSTRIES LTD.’s own tally for this item (“Elect Director: Gerald M. Lieberman”): 560,335,672 for, 133,450,043 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,132,640,597 outstanding shares: 49.5% for, 12% against (61% of the company cast a for/against vote).

The 82 asset managers below cast 75% of the shares they voted on this item FOR (81,784,469 for, 27,422,624 against).

FOR 75%AGAINST 25%

FOR: 81,784,469 (74.9%)AGAINST: 27,422,624 (25.1%)ABSTAIN: 47,616 (0.0%)

Largest asset managers voting on “Election of Directors: Gerald M. Lieberman” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Against	Vote
Fidelity	6,769,602	26,088,846	Against
Vanguard	27,522,229	0	For
BlackRock	17,219,025	0	For
Capital Group	3,159,935	0	For
Neuberger Berman	3,141,828	0	For
Charles Schwab	3,127,877	0	For
TIAA	2,586,462	0	For
SOUND SHORE FUND INC	2,193,215	0	For
Victory Capital	1,738,929	0	For
STERLING CAPITAL FUNDS	1,546,001	0	For
State Street	1,543,420	0	For
VanEck ETF Trust	1,470,688	0	For
Dimensional	929,981	0	For
Prudential/PGIM	729,624	0	For
DWS	684,256	0	For
Pacific Life	0	624,000	Against
GMO	570,822	0	For
Aberdeen	547,402	0	For
HENNESSY FUNDS TRUST	502,200	0	For
First Trust	402,147	0	For
John Hancock	375,238	0	For
CARILLON SERIES TRUST	342,600	0	For
AIG/SunAmerica	329,159	0	For
Northern Trust	0	319,140	Against
Empower	144,700	159,878	Against

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

4. Election of Directors: Prof. Varda Shalev

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%13%

FOR: 602,030,429AGAINST: 91,772,897

TEVA PHARMACEUTICAL INDUSTRIES LTD.’s own tally for this item (“Elect Director: Prof. Varda Shalev”): 602,030,429 for, 91,772,897 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,132,640,597 outstanding shares: 53.2% for, 8% against (61% of the company cast a for/against vote).

The 82 asset managers below cast 99.9% of the shares they voted on this item FOR (109,189,486 for, 17,607 against).

FOR 99.9%

FOR: 109,189,486 (99.9%)AGAINST: 17,607 (0.0%)ABSTAIN: 47,616 (0.0%)

Largest asset managers voting on “Election of Directors: Prof. Varda Shalev” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Vote
Fidelity	32,858,448	For
Vanguard	27,522,229	For
BlackRock	17,219,025	For
Capital Group	3,159,935	For
Neuberger Berman	3,141,828	For
Charles Schwab	3,127,877	For
TIAA	2,586,462	For
SOUND SHORE FUND INC	2,193,215	For
Victory Capital	1,738,929	For
STERLING CAPITAL FUNDS	1,546,001	For
State Street	1,543,420	For
VanEck ETF Trust	1,470,688	For
Dimensional	929,981	For
Prudential/PGIM	729,624	For
DWS	684,256	For
Pacific Life	624,000	For
GMO	570,822	For
Aberdeen	547,402	For
HENNESSY FUNDS TRUST	502,200	For
First Trust	402,147	For
John Hancock	375,238	For
CARILLON SERIES TRUST	342,600	For
AIG/SunAmerica	329,159	For
Northern Trust	319,140	For
Empower	304,578	For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

5. ELECTION OF DIRECTORS: Prof. Ronit Satchi-Fainaro

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

75% Majority: yes · of votes cast

FOR 75%AGAINST 25%

FOR: 517,677,574AGAINST: 176,129,338

TEVA PHARMACEUTICAL INDUSTRIES LTD.’s own tally for this item (“Elect Director: Prof. Ronit Satchi-Fainaro”): 517,677,574 for, 176,129,338 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,132,640,597 outstanding shares: 45.7% for, 16% against (61% of the company cast a for/against vote).

The 82 asset managers below cast 49.9% of the shares they voted on this item FOR (54,491,107 for, 54,715,986 against).

FOR 49.9%AGAINST 50.1%

FOR: 54,491,107 (49.9%)AGAINST: 54,715,986 (50.1%)ABSTAIN: 47,616 (0.0%)

Largest asset managers voting on “ELECTION OF DIRECTORS: Prof. Ronit Satchi-Fainaro” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Against	Vote
Fidelity	6,769,602	26,088,846	Against
Vanguard	0	27,522,229	Against
BlackRock	17,219,025	0	For
Capital Group	3,159,935	0	For
Neuberger Berman	3,141,828	0	For
Charles Schwab	3,127,877	0	For
TIAA	2,586,462	0	For
SOUND SHORE FUND INC	2,193,215	0	For
Victory Capital	1,665,640	73,289	For
STERLING CAPITAL FUNDS	1,546,001	0	For
State Street	1,543,420	0	For
VanEck ETF Trust	1,470,688	0	For
Dimensional	929,981	0	For
Prudential/PGIM	729,624	0	For
DWS	684,256	0	For
Pacific Life	0	624,000	Against
GMO	519,061	51,761	For
Aberdeen	547,402	0	For
HENNESSY FUNDS TRUST	502,200	0	For
First Trust	402,147	0	For
John Hancock	375,238	0	For
CARILLON SERIES TRUST	342,600	0	For
AIG/SunAmerica	329,159	0	For
Northern Trust	319,140	0	For
Empower	304,578	0	For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

6. Election of Directors: Rosemary A. Crane

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 6 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%AGAINST 26%

FOR: 511,812,296AGAINST: 181,995,022

TEVA PHARMACEUTICAL INDUSTRIES LTD.’s own tally for this item (“Elect Director: Rosemary A. Crane”): 511,812,296 for, 181,995,022 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,132,640,597 outstanding shares: 45.2% for, 16% against (61% of the company cast a for/against vote).

The 82 asset managers below cast 66% of the shares they voted on this item FOR (72,618,149 for, 36,588,944 against).

FOR 66%AGAINST 33%

FOR: 72,618,149 (66.5%)AGAINST: 36,588,944 (33.5%)ABSTAIN: 47,616 (0.0%)

Largest asset managers voting on “Election of Directors: Rosemary A. Crane” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Against	Vote
Fidelity	6,769,602	26,088,846	Against
Vanguard	27,522,229	0	For
BlackRock	17,219,025	0	For
Capital Group	3,159,935	0	For
Neuberger Berman	1,671	3,140,157	Against
Charles Schwab	0	3,127,877	Against
TIAA	2,586,462	0	For
SOUND SHORE FUND INC	2,193,215	0	For
Victory Capital	1,738,929	0	For
STERLING CAPITAL FUNDS	0	1,546,001	Against
State Street	1,543,420	0	For
VanEck ETF Trust	0	1,470,688	Against
Dimensional	929,981	0	For
Prudential/PGIM	634,200	95,424	For
DWS	684,256	0	For
Pacific Life	0	624,000	Against
GMO	570,822	0	For
Aberdeen	547,402	0	For
HENNESSY FUNDS TRUST	502,200	0	For
First Trust	402,147	0	For
John Hancock	375,238	0	For
CARILLON SERIES TRUST	342,600	0	For
AIG/SunAmerica	329,159	0	For
Northern Trust	319,140	0	For
Empower	159,878	144,700	For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

7. To appoint, Kesselman & Kesselman, a member of PriceWaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2025 annual meeting of shareholders.

AUDIT-RELATED

Combines 5 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 99.7%

The 77 asset managers below cast 99.8% of the shares they voted on this item FOR (105,241,649 for, 195,317 against).

FOR: 105,241,649 (99.8%)AGAINST: 195,317 (0.2%)ABSTAIN: 47,616 (0.0%)

Largest asset managers voting on “To appoint, Kesselman & Kesselman, a member of PriceWaterhouseCoopers International Ltd., as Teva's independen” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Vote
Fidelity	32,858,448	For
Vanguard	27,522,229	For
BlackRock	17,219,025	For
Capital Group	3,159,935	For
Neuberger Berman	3,141,828	For
TIAA	2,586,462	For
SOUND SHORE FUND INC	2,193,215	For
Victory Capital	1,738,929	For
STERLING CAPITAL FUNDS	1,546,001	For
State Street	1,543,420	For
VanEck ETF Trust	1,470,688	For
Dimensional	929,981	For
DWS	684,256	For
Prudential/PGIM	634,200	For
Charles Schwab	630,039	For
Pacific Life	624,000	For
GMO	570,822	For
Aberdeen	547,402	For
HENNESSY FUNDS TRUST	502,200	For
First Trust	402,147	For
CARILLON SERIES TRUST	342,600	For
AIG/SunAmerica	329,159	For
Northern Trust	319,140	For
John Hancock	306,738	For
Equitable	299,122	For

Showing the 25 largest of 77 asset managers. See all 77 in the interactive database.

8. To recommend, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation for teva s named executive officers every one, two or three years: please vote for on this resolution to approve for every 3 years

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

NOT VOTED 98%

The 17 asset managers below cast 100% of the shares they voted on this item FOR (46,529 for, 0 against).

FOR: 46,529 (0.4%)ABSTAIN: 149,543 (1.4%)NOT VOTED: 10,721,443 (98.2%)

Largest asset managers voting on “To recommend, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Abstain	Vote
Charles Schwab	0	0	Not Voted
LSV ASSET MANAGEMENT	0	0	Not Voted
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	0	0	Not Voted
NEW YORK STATE TEACHERS RETIREMENT SYSTEM	0	0	Not Voted
ETF Series Solutions	0	149,543	Abstain
Empower	0	0	Not Voted
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	0	0	Not Voted
MACKENZIE FINANCIAL CORP	0	0	Not Voted
AVIVA INVESTORS GLOBAL SERVICES LTD	0	0	Not Voted
Utah Retirement Systems	0	0	Not Voted
Prudential/PGIM	0	0	Not Voted
John Hancock	35,374	0	For
AustralianSuper Pty Ltd	0	0	Not Voted
ADVISORS' INNER CIRCLE FUND	0	0	Not Voted
Allianz	9,123	0	For
CI INVESTMENTS INC.	0	0	Not Voted
Jackson National	2,032	0	For

9. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 731,150,255AGAINST: 30,335,560

TEVA PHARMACEUTICAL INDUSTRIES LTD.’s own tally for this item (“(3) The shareholders recommended, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation for Teva's named executive officers every one year, as follows:”): 731,150,255 for, 30,335,560 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 1,132,640,597 outstanding shares: 65% for, 3% against (67% of the company cast a for/against vote).

The 15 asset managers below cast 89% of the shares they voted on this item FOR (16,719,189 for, 2,153,230 against).

FOR 89%11%

FOR: 16,719,189 (88.6%)AGAINST: 2,153,230 (11.4%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Against	Vote
GLENVIEW CAPITAL MANAGEMENT, LLC	9,864,670	0	For
Eversept Partners, LP	5,393,804	0	For
APG Asset Management US Inc.	0	1,857,596	Against
ADAGE CAPITAL PARTNERS GP, L.L.C.	527,000	0	For
JPMorgan	410,494	0	For
TD ASSET MANAGEMENT INC	316,815	0	For
Desjardins Global Asset Management Inc.	0	265,689	Against
Empower	159,908	0	For
Brighthouse	44,232	0	For
Regime de rentes du Mouvement Desjardins	0	29,935	Against
NTV ASSET MANAGEMENT LLC	1,850	0	For
Douglass Winthrop Advisors, LLC	300	0	For
Balentine LLC	116	0	For
MILLER HOWARD INVESTMENTS INC /NY	0	10	Against
IPConcept (Luxemburg) S.A.	0	0	--

10. To recommend, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation for teva s named executive officers every one, two or three years: please vote for on this resolution to approve for every 1 year

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99%

The 15 asset managers below cast 100% of the shares they voted on this item FOR (10,905,304 for, 0 against).

FOR: 10,905,304 (98.6%)ABSTAIN: 149,543 (1.4%)

Largest asset managers voting on “To recommend, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Abstain	Vote
Charles Schwab	4,995,676	0	For
LSV ASSET MANAGEMENT	3,027,564	0	For
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	1,933,139	0	For
NEW YORK STATE TEACHERS RETIREMENT SYSTEM	249,200	0	For
ETF Series Solutions	0	149,543	Abstain
Empower	144,700	0	For
Prudential/PGIM	135,790	0	For
USS Investment Management Ltd	88,437	0	For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	78,466	0	For
MACKENZIE FINANCIAL CORP	71,083	0	For
AVIVA INVESTORS GLOBAL SERVICES LTD	69,005	0	For
Utah Retirement Systems	65,587	0	For
AustralianSuper Pty Ltd	27,156	0	For
ADVISORS' INNER CIRCLE FUND	14,100	0	For
CI INVESTMENTS INC.	5,401	0	For

11. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 62%ONE YEAR 37%

The 15 asset managers below cast 99.9% of the shares they voted on this item FOR (30,272,984 for, 10 against).

FOR: 30,272,984 (61.6%)AGAINST: 10 (0.0%)ONE YEAR: 18,343,413 (37.3%)1-YEAR: 527,000 (1.1%)

Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Against	Vote
Migdal Insurance Co Ltd	29,857,800	0	For
GLENVIEW CAPITAL MANAGEMENT, LLC	0	0	One Year
Eversept Partners, LP	0	0	One Year
APG Asset Management US Inc.	0	0	One Year
ADAGE CAPITAL PARTNERS GP, L.L.C.	0	0	1-Year
JPMorgan	0	0	One Year
BECK MACK & OLIVER LLC	410,184	0	For
TD ASSET MANAGEMENT INC	0	0	One Year
Desjardins Global Asset Management Inc.	0	0	One Year
Empower	0	0	One Year
Brighthouse	0	0	One Year
Regime de rentes du Mouvement Desjardins	0	0	One Year
Corient Private Wealth LLC	5,000	0	For
Douglass Winthrop Advisors, LLC	0	0	One Year
MILLER HOWARD INVESTMENTS INC /NY	0	10	Against

12. To recommend, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation for teva s named executive officers every one, two or three years: please vote for on this resolution to approve abstain

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

— fund support · no official result

NOT VOTED 99%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ABSTAIN: 149,543 (1.4%)NOT VOTED: 10,721,443 (98.6%)

Largest asset managers voting on “To recommend, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	Abstain	Vote
Charles Schwab	0	Not Voted
LSV ASSET MANAGEMENT	0	Not Voted
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	0	Not Voted
NEW YORK STATE TEACHERS RETIREMENT SYSTEM	0	Not Voted
ETF Series Solutions	149,543	Abstain
Empower	0	Not Voted
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	0	Not Voted
MACKENZIE FINANCIAL CORP	0	Not Voted
AVIVA INVESTORS GLOBAL SERVICES LTD	0	Not Voted
Utah Retirement Systems	0	Not Voted
Prudential/PGIM	0	Not Voted
AustralianSuper Pty Ltd	0	Not Voted
ADVISORS' INNER CIRCLE FUND	0	Not Voted
CI INVESTMENTS INC.	0	Not Voted

13. To recommend, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation for teva s named executive officers every one, two or three years: please vote for on this resolution to approve for every 2 years

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

— fund support · no official result

NOT VOTED 99%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ABSTAIN: 149,543 (1.4%)NOT VOTED: 10,721,443 (98.6%)

Largest asset managers voting on “To recommend, on a non-binding advisory basis, to hold a non-binding advisory vote to approve the compensation” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	Abstain	Vote
Charles Schwab	0	Not Voted
LSV ASSET MANAGEMENT	0	Not Voted
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	0	Not Voted
NEW YORK STATE TEACHERS RETIREMENT SYSTEM	0	Not Voted
ETF Series Solutions	149,543	Abstain
Empower	0	Not Voted
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	0	Not Voted
MACKENZIE FINANCIAL CORP	0	Not Voted
AVIVA INVESTORS GLOBAL SERVICES LTD	0	Not Voted
Utah Retirement Systems	0	Not Voted
Prudential/PGIM	0	Not Voted
AustralianSuper Pty Ltd	0	Not Voted
ADVISORS' INNER CIRCLE FUND	0	Not Voted
CI INVESTMENTS INC.	0	Not Voted

14. TO APPOINT, KESSELMAN AND KESSELMAN, A MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LTD., AS TEVA'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM UNTIL TEVA'S 2025 ANNUAL MEETING OF SHAREHOLDERS

AUDIT-RELATED

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 10 asset managers below cast 100% of the shares they voted on this item FOR (3,566,017 for, 0 against).

FOR: 3,566,017 (100.0%)

Largest asset managers voting on “TO APPOINT, KESSELMAN AND KESSELMAN, A MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LTD., AS TEVA'S INDEPEND” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Vote
Charles Schwab	2,497,838	For
ETF Series Solutions	299,086	For
JPMorgan	270,390	For
Jackson National	166,636	For
Empower	144,700	For
Prudential/PGIM	95,424	For
John Hancock	68,500	For
ADVISORS' INNER CIRCLE FUND	14,100	For
Allianz	9,123	For
Boltwood Capital Management	220	For

15. 14A Executive Compensation

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (317,382 for, 0 against).

FOR: 317,382 (100.0%)

Largest asset managers voting on “14A Executive Compensation” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Vote
DME Capital Management, LP	311,639	For
Williamson Legacy Group, LLC	5,713	For
BALLAST ADVISORS LLC	30	For

16. 14A Executive Compensation Vote Frequency

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

1 YEAR 98%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

1 YEAR: 311,639 (98.2%)3 YEARS: 5,713 (1.8%)

Largest asset managers voting on “14A Executive Compensation Vote Frequency” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
DME Capital Management, LP	0	0	0	0	1 Year
Williamson Legacy Group, LLC	0	0	0	0	3 Years

17. To Approve, on a Non-Binding Advisory Basis, the Compensation for Named Executive Officers

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (4,797,951 for, 0 against).

FOR: 4,797,951 (100.0%)

Largest asset managers voting on “To Approve, on a Non-Binding Advisory Basis, the Compensation for Named Executive Officers” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
SOUND SHORE MANAGEMENT INC /CT/	2,604,736	0	0	0	For
SOUND SHORE FUND INC	2,193,215	0	0	0	For

18. To Recommend, on a Non-Binding Basis, to Hold a Non-Binding Advisory Vote to Approve the Compensation for Teva's Named Executive Officers Every One, Two or Three Years

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

1 YEAR 54.3%ONE YEAR 45.7%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

1 YEAR: 2,604,736 (54.3%)ONE YEAR: 2,193,215 (45.7%)

Largest asset managers voting on “To Recommend, on a Non-Binding Basis, to Hold a Non-Binding Advisory Vote to Approve the Compensation for Teva” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
SOUND SHORE MANAGEMENT INC /CT/	0	0	0	0	1 Year
SOUND SHORE FUND INC	0	0	0	0	One Year

19. To approve, on a non-binding advisory basis, the compensation of Teva's named executive officers

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (1,434 for, 0 against).

FOR: 1,434 (100.0%)

Largest asset managers voting on “To approve, on a non-binding advisory basis, the compensation of Teva's named executive officers” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
BRAVE ASSET MANAGEMENT INC	1,352	0	0	0	For
1620 INVESTMENT ADVISORS, INC.	82	0	0	0	For

20. Ratify Kesselman & Kesselman as Auditors

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (204,110 for, 0 against).

FOR: 204,110 (100.0%)

Largest asset managers voting on “Ratify Kesselman & Kesselman as Auditors” at TEVA PHARMACEUTICAL INDUSTRIES LTD., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Empower	159,878	0	0	0	For
Brighthouse	44,232	0	0	0	For

Largest TEVA PHARMACEUTICAL INDUSTRIES LTD. shareholders voting in 2023-2024

Ranked by the number of TEVA PHARMACEUTICAL INDUSTRIES LTD. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 1,132,640,597 shares outstanding at the time of that meeting.

Top TEVA PHARMACEUTICAL INDUSTRIES LTD. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	Fidelity	5.80%
2	BlackRock	4.30%
3	Vanguard	3.38%
4	Harel Insurance Investments & Financial Services Ltd.	2.92%
5	MENORA MIVTACHIM HOLDINGS LTD.	2.55%
6	Clal Insurance Enterprises Holdings Ltd	2.46%
7	Slate Path Capital LP	2.37%
8	Lingotto Investment Management LLP	1.60%
9	State Street	1.44%
10	Rubric Capital Management LP	1.34%

Reported TEVA PHARMACEUTICAL INDUSTRIES LTD. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

TEVA PHARMACEUTICAL INDUSTRIES LTD. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
BlackRock	5.10%	13F
FMR (Fidelity)	2.18%	13F
State Street	1.43%	13F
Millennium Management	0.98%	13F
Goldman Sachs	0.85%	13F
Citadel Advisors	0.73%	13F
Geode Capital	0.72%	13F
Renaissance Technologies	0.68%	13F
Morgan Stanley	0.57%	13F
Northern Trust	0.31%	13F

Percentages above are of 1,132,640,597 shares outstanding, as reported by TEVA PHARMACEUTICAL INDUSTRIES LTD. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TEVA PHARMACEUTICAL INDUSTRIES LTD.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At TEVA PHARMACEUTICAL INDUSTRIES LTD.'s shareholder meeting held 2024-06-06, in the 2023-2024 proxy season, 490 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,105 separate fund positions. Their filings are grouped here into 20 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. TEVA PHARMACEUTICAL INDUSTRIES LTD.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on a non-binding advisory basis, the compensation for Teva's named executive… — the reporting funds cast 91% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

TEVA PHARMACEUTICAL INDUSTRIES LTD. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.